SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042635
Filing Date
2021-08-09
Accepted
2021-08-09 16:11:00
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20210630.htm   iXBRL 10-Q 1975051
2 EX-31.1 reta-ex311_7.htm EX-31.1 20424
3 EX-31.2 reta-ex312_10.htm EX-31.2 20171
4 EX-32.1 reta-ex321_9.htm EX-32.1 9902
5 EX-32.2 reta-ex322_8.htm EX-32.2 10013
6 GRAPHIC ghepfcw5boji000002.jpg GRAPHIC 41422
7 GRAPHIC ghepfcw5boji000001.jpg GRAPHIC 75047
  Complete submission text file 0001564590-21-042635.txt   5776512

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA reta-20210630.xsd EX-101.SCH 44599
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20210630_cal.xml EX-101.CAL 32349
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20210630_def.xml EX-101.DEF 135870
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20210630_lab.xml EX-101.LAB 317918
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20210630_pre.xml EX-101.PRE 233732
13 EXTRACTED XBRL INSTANCE DOCUMENT reta-10q_20210630_htm.xml XML 710137
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 211156578
SIC: 2834 Pharmaceutical Preparations